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Intrasac flow velocities predict sealing of type II
endoleaks after endovascular abdominal aortic
aneurysm repair
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Purpose: The purpose of this study was to determine whether intrasac spectral Doppler flow velocities can predict
whether or not a type II endoleak will spontaneously seal and to relate intrasac flow to preoperative branch vessel
anatomy.
Methods: Between October 1996 and June 2002, 265 patients with abdominal aortic aneurysms underwent endovascular
repair. Patients with less than 24 months of follow-up and type I endoleaks were excluded. Type II endoleaks were
confirmed with duplex scan and computed tomographic angiography. Two groups were identified: 14 patients with
sealed endoleaks (<6 months) without intervention and 16 patients with persistent endoleaks greater than 6 months and
without resolution. Spectral Doppler flow velocities were recorded from endoleaks within the aneurysm sac.
Results: The two groups were similar in age, demographics, and aneurysm morphology. The mean follow-up times were
29.9  7.9 months for sealed endoleaks and 30.2  8.6 months for persistent endoleaks (P  not significant). Spectral
Doppler velocities were significantly lower in patients with sealed endoleaks compared with persistent endoleaks (75.5
78.8 cm/s versus 138.2  36.2 cm/s; P < .01). Patients with sealed endoleaks and low (<100 cm/s) intrasac Doppler
velocities had significantly fewer patent inferior mesenteric arteries (43% versus 81%; P < .01), a smaller inferior
mesenteric artery (5.6 1.8 mm versus 7.2 1.3 mm; P < .01), and fewer paired lumbar arteries (1.3 0.8 versus 2.4
0.6; P < .0001) compared with those with persistent endoleaks and high (>100 cm/s) intrasac flow velocities. Three
patients with sealed endoleaks had Doppler velocities of 200 cm/s or greater. However, the diameter of the inferior
mesenteric artery in these patients was 4 mm or less with no visualized lumbar arteries before surgery. Aneurysm
diameter(4.6  5.6 mm) and volume (0.9  45.2 mL) decreased in patients with sealed endoleaks. Aneurysm
diameter (1.8 4.9 mm) and volume (18.5 33.9 mL) increased slightly in patients with persistent endoleaks (P < .05).
No ruptures or conversions occurred in any patient. Secondary interventions to treat type II endoleaks were unsuccessful
in six of 16 patients (38%) with persistent endoleaks.
Conclusion: Intrasac Doppler velocities can be used to predict whether a type II endoleak will spontaneously seal.
High-velocity type II endoleaks are related to preoperative large branch vessel diameter and number and are resistant to
endovascular treatment. (J Vasc Surg 2003;37:8-15.)
Endovascular repair offers a less invasive treatment
option for patients with infrarenal abdominal aortic aneu-
rysms (AAAs); however, the long-term effectiveness of
endovascular grafting is unknown. Despite a high technical
success rate in the placement of endovascular grafts, persis-
tent flow within the aneurysm sac (endoleaks) can be
identified in 15% to 52% of patients after endovascular
repair.1-6 Although the true significance of endoleaks is
unknown, there is little debate that type I endoleaks asso-
ciated with poor proximal or distal fixation are associated
with continued risk of aneurysm rupture and need treat-
ment. However, the significance of type II endoleaks on
long-term outcome is unknown.
Type II endoleaks are the result of continued flow
within the aneurysm sac from the inferior mesenteric artery
(IMA) or lumbar arteries. Such endoleaks are often seen
immediately after placement of an endovascular device and
are more likely to persist in patients with a large-caliber
IMA or with multiple patent lumbar arteries. To date, there
is no consensus as to the relevance, treatment, or outcome
of these endoleaks. It is not known whether treatments
aimed at occluding these branch vessels to eliminate the
type II endoleak reduces the subsequent risk of rupture.
Although some investigators recommend an aggressive ap-
proach with transarterial or translumbar embolization, li-
gation, or surgical conversion, others recommend no treat-
ment unless there is evidence of aneurysm enlargement or
endograft migration.7-9 The purpose of this study was to
determine whether the velocity of blood flow in the aneu-
rysm sac as measured with intrasac spectral velocities can
predict whether or not a type II endoleak will spontane-
ously seal without intervention and to relate flow velocities
to preoperative branch vessel anatomy.
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Patients. Between October 1996 and June 2002, 265
patients with infrarenal AAAs underwent endovascular re-
pair with the AneuRx stent graft (n  252; Medtronic
AVE, Santa Rosa, Calif) or Talent stent graft (n  13;
Medtronic AVE). All patients were captured in a vascular
database. Sixty-one patients (23%) had a type II endoleak at
discharge. Of these, 30 patients had evidence of a type II
endoleak identified before hospital discharge on both com-
puted tomographic angiography (CTA) and duplex ultra-
sound scan (DUS). These patients had repeat assesment of
their endoleaks with both imaging methods with complete
agreement in follow-up. Endoleaks that disappeared within
6 months with no subsequent recurrence, and without
treatment, were classified as sealed. Endoleaks that per-
sisted longer than 6 months were classified as persistent
type II endoleaks. There were 14 patients with sealed
endoleaks and 16 patients with persistent endoleaks.
Imaging and aneurysm morphology. Preoperative
and postoperative CTA and three-dimensional reconstruc-
tions were used to determine aneurysm morphology. Pre-
operative measurements included AAA diameter and vol-
ume. After surgery, changes in aneurysm diameter and
volume were determined from serial measurements at dis-
charge, at 1, 3, and 6 months, and yearly thereafter.
Before hospital discharge, patients underwent evalua-
tion with CTA, DUS, and abdominal radiography to eval-
uate the position and integrity of the stent graft. Among the
265 patients, postoperative imaging surveillance was per-
formed with CTA. Among the 265, 71 patients underwent
both CTA and DUS with at least a 3-year follow-up before
discharge and at 1, 3, and 6 months and yearly thereafter as
a result of physician preference. Of these 71, 31 patients
had no evidence of endoleak with CTA or DUS, five had
type I endoleaks that were treated, four lacked sufficient
imaging confirmation of endoleak, and one died within 30
days, leaving 30 patients to be analyzed for this study.
Endoleak assessment. The combination of DUS and
CTA allowed accurate identification of the source of any
endoleak and exclusion of patients with type I endoleaks.
DUS was performed by a registered vascular technologist
with a Sequoia 512 ultrasound system (Acuson, Mountain
View, Calif) and a Sector V4 transducer. After the patients
had fasted for 6 hours, transverse and sagittal imaging was
performed to measure peak systolic diameters at the largest
region of the proximal, mid, and distal segments of the
abdominal aorta. Close attention was given to the stent
device in grayscale and color Doppler scanning of the
aneurysm sac to rule out endoleak. Duplex scan was used to
determine presence or absence of flow in the aneurysm sac
and branch vessels (Fig 1). Quantitative assessment of flow
velocities and direction was performed within the aneurysm
sac near the aneurysm wall with a constant angle of less than
60 degrees to the branch vessel (Figs 2 and 3). Spectral
velocities were obtained at the entrance of the feeding
vessel to the aneurysm sac only. No velocities were obtained
within the aneurysm sac or in the outflow vessel. All scans
where reviewed by a vascular surgeon and were technically
satisfactory in each case in this series.
Spiral computed tomographic scan was performed with
a Lightspeed Qxi computed tomographic scanner (General
Electric Medical Systems, Milwaukee, Wis). Precontrast
studies were performed routinely. After preliminary timing
of 15 mL of iodinated contrast bolus, 80 to 150 mL of
nonionic iodinated contrast medium were injected at 4
mL/s. Computed tomographic scans were acquired at
pitch 6.0 with a 2.5-mm nominal section thickness
throughout the entire scan. All images were reconstructed
at intervals equal to 50% of nominal section thickness and
viewed interactively on a workstation.
Preoperative collateral vessel quantification. IMA
patency was defined as visualization of the vessel in com-
munication with aneurysm on preoperative CTA. The di-
ameter was measured from outer wall to outer wall with
electronic calipers on three-dimensional reconstructions.
Three independent measurements were obtained and aver-
aged. Similarly, all lumbar arteries visualized on the preop-
erative CTA from the renal arteries to the level of the aortic
bifurcation were counted as paired lumbar arteries.
Statistical analysis. Results are expressed as the
mean  the standard deviation. Differences between
groups were compared with the Student t test. Cox pro-
portional hazards regression analysis was used to identify
independent risk factors for type II endoleaks with elevated
spectral velocites. Kaplan-Meier estimates were used to
determine freedom from surgical conversion and aneurysm
rupture. A P value of less than .05 were considered signif-
icant.
RESULTS
There was no difference in gender, age, or comorbidi-
ties in patients with sealed or persistent endoleaks. The
mean follow-up period was the same: 29.9  7.9 months
(range, 24 to 48 months) for sealed endoleaks and 30.2 
8.6 months (range, 24 to 49 months) for persistent en-
doleaks.
Preoperative aneurysm morphology. There was no
significant difference between the two groups with regards
to the proximal neck diameter or length (Table I). Patients
with sealed endoleaks had larger aneurysms (63.4  11.4
mm; range, 46 to 80 mm) than those with persistent
endoleaks (55.6 4.2 mm; range, 47 to 62 mm; P .05).
Intrasac flow velocities and preoperative branch
vessel anatomy. Intrasac Doppler flow velocities of type
II endoleaks at the time of hospital discharge were different
between the two groups. Patients with type II endoleaks
that sealed in less than 6 months without intervention had
significantly lower intrasac AAA flow velocities at the time
of hospital discharge than patients with persistent type II
endoleaks (75.5  78.8 cm/s; range, 15 to 230 cm/s;
versus 138.2  36.2 cm/s; range, 100 to 200 cm/s; P 
.01). These elevated intrasac AAA flow velocities were
directly related to whether or not the IMA was patent (P
.01) and whether or not more than two paired lumbar
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arteries were patent (P  .0001) on the preoperative CTA
(Table II).
Three patients with sealed endoleaks had high flow
velocities of 200 cm/s or greater. However, in these pa-
tients, the diameter of the IMA was less than 4 mm and no
lumbar arteries were visualized before surgery. The other
11 patients all had intrasac flow velocities of less than 80
cm/s.
Intrasac flow velocity had decreased to zero in all
patients with sealed endoleaks within 6 months, and lack of
endoleak was confirmed with CTA in each instance. Pa-
tients with persistent endoleaks continued to have elevated
intrasac flow velocities that remained greater than 100
cm/s during the follow-up period and did not change
significantly over time (Fig 4).
Secondary interventions. Coil embolization of
branch and collateral vessels was attempted in six of 16
patients (38%) with persistent type II endoleaks and high
intrasac flow velocities in an effort to seal the type II
endoleak. Four lumbar arteries and two IMAs were coil
embolized via the hypogastric and superior mesenteric
artery, respectively. The mean time to secondary transcath-
eter intervention was 16.6 months (range, 6 to 24 months).
Although each procedure was technically successful in elim-
inating the endoleak angiographically at the time of the
procedure, none of the type II endoleaks was completely
obliterated with follow-up duplex scan imaging that was
performed 3 months after intervention. Furthermore, in
each instance, the velocities remained greater than 100
cm/s. In one patient with a persistent type II endoleak with
high intrasac flow velocities (175 cm/s) and transarterial
embolization of lumbar arteries, there was a significant
increase in AAA diameter (58 mm to 72 mm) and volume
(290 mL to 400 mL) over 26 months. The patient under-
went laparoscopic clipping of the IMA and a lumbar vessel.
Before clipping, the mean intrasac pressure was 60 mm Hg
and nonpulsatile. After the clipping, the intrasac pressure
decreased to 20 mm Hg. The endoleak resolved, and over
the last 20 months, the diameter and volume of the aneu-
rysm have remained stable.
Postoperative morphology. In patients with sealed
type II endoleaks, the aneurysm diameter (4.6  5.6
mm) and volume (0.9  45.2 ml) decreased compared
Fig 1. DUS shows extrastent flow after infrarenal AAA repair with stent graft. Endoleak is result of patent preoperative
IMA.
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with patients with persistent type II endoleaks where the
aneurysm diameter (1.8  4.9 mm) and volume (18.5 
33.9 ml) increased compared with the preoperative aneu-
rysm sac dimensions (P  .05).
Clinical outcome. There were no aneurysm ruptures
or surgical conversions in any of the patients with either
sealed or persistent type II endoleaks at 36 months.
DISCUSSION
The significance of type II endoleaks is unknown. The
finding that systemic pressure can often be recorded in the
aneurysm sacs of patients with type II endoleaks has caused
some investigators to treat these leaks aggressively while
others treat only when the aneurysm sac is increasing in
size. Treatment options are varied and include transcathe-
ter interventions with transarterial and translumbar coil
embolizations and direct thrombin injection of the aneu-
rysm sac, which have yielded mixed results.8-11 Although
the best treatment option (or no treatment) for these
patients is being studied and debated, there have been little
data regarding the physiology or classification of type II
endoleaks.
Most patients who undergo endovascular AAA repair
have postoperative surveillance with CTA. This imaging
study can usually determine the presence or absence of a
type II endoleak and differentiate these from type I attach-
ment site endoleaks.12 Type II endoleaks are often de-
scribed qualitatively as being large or small depending on
the volume of contrast seen in the aneurysm sac. Preoper-
ative documentation of a large IMA or multiple patent
lumbar arteries has been shown to be predictive evidence
for the persistence of type II endoleaks after surgery.7,13
This may be due to high flow rates in these large branch
vessels. Although CTA allows for excellent visualization of
the AAA, aortic anatomy and tortuosity, and the stent graft,
it offers little physiologic data. The use of DUS is helpful in
this regards; it can be used to further characterize these type
II endoleaks after surgery. Thus, the use of DUS both
compliments and adds to the information obtained on
CTA.
Fig 2. DUS and spectral velocities of type II endoleak after infrarenal AAA repair with endovascular graft. To and fro
flow is seen within aneurysm during systole and diastole, respectively. For this study, spectral flow velocities were
obtained adjacent to aneurysm wall (above-right image). This patient had persistent endoleak with postoperative
velocities between 190 and 200 cm/s. It is important to notice position of where velocities were measured because
velocities will decrease if flow is measured further away from wall (bottom-right image).
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DUS has been widely used for morphologic surveil-
lance of AAAs and also provides information on blood flow
velocities and patterns. It is the procedure of choice for
noninvasive imaging of the AAA and offers the advantages
of wide availability, lower cost, no radiation exposure,
noninvasiveness, and no nephrotoxicity compared with
CTA, magnetic resonance angiography, and arteriography.
DUS offers the additional advantage of being able to doc-
ument flow vewlocity and direction in the aneurysm sac and
branch vessels entering the aneurysm, thus providing dy-
namic flow information that is not possible with CTA.
Table II. Preoperative collateral vessel quantification and






(n  16) P value
Intrasac AAA Doppler
flow velocities (cm/s)
75.5  78.8 138.2  36.2 .01
IMA patent 43% 81% .01
IMA diameter (mm) 5.6  1.8 7.2  1.3 .01
Paired lumbar arteries 1.3  0.8 2.4  0.6 .0001
Fig 3. DUS of type II endoleak from IMA. Spectral flow velocities within aneurysm sac near wall are 19 cm/s. This
endoleak resolved spontaneously and has not recurred on follow-up imaging.




(n  16) P value
Proximal neck diameter (mm) 21.7  1.8 (19-25) 22.6  1.6 (19-26) NS
Proximal neck length (mm) 21.2  9.4 (10-40) 22.6  10.3 (10-46) NS
AAA size (mm) 63.4  11.4 (46-80) 55.6  4.2 (47-62) .04
Data are mean  standard deviation (range).
NS, Not significant.
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We have previously shown that high-quality DUS is
comparable with CTA for measuring aneurysm size and for
identifying endoleaks after endovascular exclusion of AAA.
The maximal transverse diameter as measured with duplex
scanning (60.0  9.8 mm) correlated closely (r  0.93;
P .001) with CTA (58.8 8.5 mm). In 92% of the scans,
diameter measurements were within 5 mm of each other.
Changes in aneurysm size throughout follow-up were
2.4  5.8 mm on duplex scanning and 2.4  4.7 mm
on CTA without a significance difference. Both imaging
methods were able to determine the presence or absence of
endoleak with excellent correlation (P .001). In compar-
ison with CTA, diagnosis of endoleak with duplex scanning
was associated with a sensitivity of 81%, a specificity of 95%,
a positive predictive value of 94%, and a negative predictive
value of 90%.12 Thus, the use of DUS is a valid technique in
the surveillance of AAA after endovascular repair.
Because of the uncertainty and consequences of type II
endoleaks, some physicians choose to treat endoleaks as
soon as they are seen on follow-up CTA.9,10 This strategy is
often not always effective in obliterating the endoleak.
Because it is not clear that the presence of a type II endoleak
exposes the patient to a significant risk of aneurysm rupture,
it is possible that some patients are undergoing unnecessary
interventions for type II endoleaks that may obliterate
spontaneously.
We evaluated two groups of patients with type II en-
doleaks, those that sealed within 6 months and those with
persistent type II endoleaks. DUS of these two different
types of endoleaks showed two different flow characteris-
tics. Those with persistent endoleaks had significantly
higher intrasac flow velocities than those with sealed en-
doleaks. This increased flow velocity corresponded with an
increased number of patent preoperative collateral vessels.
Knowledge of whether a type II endoleak has low or high
intrasac flow velocities can be used to select patients for
treatment because patients with low intrasac flow velocities
are likely to have complete thrombosis of the aneurysm sac
and disappearance of the endoleak without the need for
treatment. The sluggish flow within the aneurysm sac may
facilitate thrombosis of the endoleak. This watchful waiting
of low velocity type II endoleaks during the initial 6 months
after stent graft placement can decrease the number of
percutaneous interventions performed and decrease the
morbidity and mortality associated with added hospitaliza-
tions and procedures. Furthermore, in this group of pa-
tients with sealed endoleaks, within 6 months, there was a
decrease in both aneurysm volume and diameter.
The presence of high-velocity type II endoleaks appears
to be related to the presence of multiple patent preoperative
collateral vessels. One could argue that these collateral
branch vessels should be treated before surgery before stent
graft placement. However, this is not our strategy because
the overall significance of high velocity type II endoleaks is
still unknown. In this small group of patients, there has
been little change in aneurysm size and no aneurysm rup-
tures or conversions. Although there was an overall minor
increase in the mean diameter (1 mm) and volume in
patients with persistent endoleaks, only two patients (13%)
had an actual increase in size and one (6%) had a decrease.
This is in contrast to patients with low-velocity type II
endoleaks, which sealed with subsequent shrinkage of the
aneurysm sac. Interestingly, patients with sealed endoleaks
had larger aneurysms than those with persistent endoleaks.
Fig 4. Comparison of postoperative intrasac flow velocities to intrasac flow velocities at last follow-up in patients with
persistent type II endoleaks. Mean follow-up period is 29.9 months. Over time, there is little change in intrasac systolic
velocities even in those who underwent transarterial coil embolization. One patient with laparascopic clipping of IMA
and lumbar artery had complete resolution of endoleak (patient 5).
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What effect this increased size has on type II endoleaks is
unknown. However, the increased size and thrombus
within the sac may have provided more resistance, further
allowing the type II endoleak to seal. This will require
further study in the future.
Six patients underwent transarterial coil embolization
during our early endograft experience. These were per-
formed to obliterate all extrastent flow when there were
little data to support either conservative management or
aggressive intervention. However, in our experience, type
II endoleaks with high intrasac flow velocities appear resis-
tant to transarterial coil embolization. Whether they are
resistant to other therapies, including translumbar emboli-
zation or thrombin injection of the AAA sac, is unknown
from this study. Future studies looking at these therapies
should attempt to classify type II endoleaks into low and
high intrasac flow velocities to determine whether these
interventions are more effective than transarterial emboli-
zation.
The long-term outcome for patients with persistent
high flow type II endoleaks has thus far been no different
from patients without endoleaks or sealed endoleaks. Free-
dom from surgical conversion and aneurysm rupture was
100% at 3 years. Thus, we treat type II endoleaks conser-
vatively. Patients with type II endoleaks with a stable or
decreasing aneurysm are routinely followed on a biannual
basis. However, patients with a type II endoleak and an
increase in aneurysm size are treated. Treatment includes
ensuring secure proximal and distal stent graft fixation from
just at the level of the renal arteries to the hypogastric
arteries bilaterally and no evidence of type I endoleak. If
there is continued increase in aneurysm size, treatment with
translumbar coil embolization or thrombin injection of the
aneurysm sac can be attempted, although the long-term
success of this approach is not clear. However, laparascopic
clipping of these vessels was feasible and was successfully
used in one patient. This method of treatment may become
more useful in the future but is often technically challeng-
ing.
In conclusion, intrasac flow Doppler velocities can be
used to predict whether type II endoleaks will spontane-
ously seal. Patients with low-velocity endoleaks (80
cm/s) are likely to have thrombosis without treatment.
Those with high velocity (100 cm/s) are related to
preoperative large branch vessel diameter and number.
These appear resistant to treatment with transarterial em-
bolization. Categorization of type II endoleaks into high-
velocity and low-velocity endoleaks with DUS can be used
to test different therapeutic interventions for type II en-
doleaks in the future. In this group of patients, type II
endoleaks are not associated with aneurysm rupture or
surgical conversion. Longer follow-up is needed to confirm
these observations.
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DISCUSSION
Dr George H. Meier III (Norfolk, Va). We have had a
long-standing interest in endoleak detection with ultrasound, and I
am sure you have seen our papers on flow spectrum. And obviously,
when you talk about duplex, there are a lot of other parameters you
can get.
Clearly, some of those parameters that we are concerned about
are resistive indices, the presence of diastolic flow, and also volume
flows. And the first question I would ask is, are there any data, do
you have any data, on those specific criteria? Since we did not find
peak flow velocities predictive.
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The second issue is, what happens to these waveforms over
time? We have also put our opinion out there in the literature on
what that means. We feel that flow spectrum often change before
these endoleaks occlude, and I was wondering if you found any
evidence of that in your series?
Dr Frank R. Arko. With regard to the flow velocities over
time, patients with the sealed endoleaks decreased to zero without
evidence of flow within the aneurysm sac.
In the patients with persistent type II endoleaks, the flow
velocities remained relatively unchanged from their immediate
postoperative state in that they continued to range in the 100 to
200 cm/s range. In the patients with transarterial embolization,
there was some decrease in the flow velocities, but never below 100
cm/s.
Regarding resistive indices, we did not look at these so I do
not have any data to share. It is important to note that in patients
with persistent type II endoleaks there was both to-and-fro flow
during systole and diastole.
Dr John J. Ricotta (Stony Brook, NY). I just wanted a
clarification. Did you redo the Dopplers after your transarterial
embolization, and did the flow velocities change? I do not under-
stand, maybe you could speculate on it, since your hypothesis is
that flow velocity predicts the sealing, and presumably you change
the flow velocity with the transarterial embolization, can you
speculate on why that did not effectively seal these endoleaks?
Dr Arko. After patients underwent transarterial emboliza-
tion, they did not immediately have color duplex imaging per-
formed as this was a retrospective study. CTA and duplex were
performed between 3 and 6 months later with an endoleak present
on both studies. The velocities did decrease, but again, they
remained in the elevated range from 100 to 200 cm/s. I suspect
that several of these patients had multiple lumbar arteries and not
all of them were embolized. So I suspect that the endoleaks
persisted as a result of continued flow in the lumbars that were not
embolized.
Dr David C. Brewster (Boston, Mass). I just want to make
sure that we understand the clinical implications of your findings.
Is it fair to say that your data would suggest that type II endoleaks
are not really clinically relevant and therefore that intervention of
persistent endoleaks would not be indicated?
Dr Arko. I am not sure that I would go so far as to say that all
type II endoleaks are clinically insignificant. However, I think our
data suggest that management of type II endoleaks with coil
embolizations within 3 months is an aggressive strategy, especially
when there is no increase in aneurysm size.
Patients with type II endoleaks that have an increase in aneu-
rysm size should be treated. However, coil embolization of these
endoleaks via a transarterial route has not been very successful. A
translumbar approach may be better, and we have had some
success with thrombin injection of the aneurysm sac. One patient
who had elevated velocities underwent transarterial embolization
that failed, and the aneurysm continued to increase in size. There
was secure proximal and distal fixation of the stent graft. The
patient underwent laparoscopic ligation of the IMA and one
lumbar artery. That patient’s aneurysm initially increased from 55
mm to 72 mm during that time period prior to laparoscopic
ligation. Intrasac pressures during the procedure were 60 mm Hg
and nonpulsatile. Following the clipping, the pressures decreased
down to 20 mm Hg and there has been no further increase in
aneurysm size and no endoleak.
So, I think in patients who have an increase in aneurysm size,
they should be treated. But otherwise, I think if there is no increase
in size, or there is a decrease, I think they can be safely followed.
That has been our experience.
ANNOUNCING A NEW SECTION: VASCULAR IMAGES
The Vascular Images section presents interesting vascular images and associated short educational summaries in a
focused, case report format. One of the images will be chosen for the cover of each issue of the Journal. Submission
of color illustrations suitable for the Journal cover is encouraged. Appropriate images include radiographs, pathology,
anatomy, operative findings, and other relevant clinical pictures. The images should illustrate features of vascular
disease, including technical approaches. Illustrations and text must be confined to one printed page (no more than
350 words; perhaps less depending on the number and size of illustrations), and images for the cover should possess
both scientific and artistic merit. Descriptions of images must be included in the text, and only key references should
be provided (with a limit of two). Images must be of professional quality and should be provided electronically in
either TIFF or EPS format and uploaded (with the rest of the manuscript) via the Editorial Manager electronic
submission system at http://jvs.editorialmanager.com. Detailed artwork instructions and help with formatting,
sizing, scanning, and file naming can be found at http://www.elsevier.nl/homepage/sab/artwork. A high-
quality print or computer-generated image of each illustration must be submitted to the Journal office for accepted
submissions, even though the illustrations have been submitted previously via Editorial Manager. For more
information regarding hard copy requirements, please see “Guidelines to Complete Submission of an Accepted
Manuscript” at http://jvs.editorialmanager.com.
Contributions for the Vascular Images section are now invited.
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